BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Advaxis Inc.

Headquarters: Princeton, NJ, United States of America
Website: N/A
Year Founded: 2002
Status: Merged

BioCentury | Nov 2, 2022
Management Tracks

Cox to head digital health at Pfizer

Plus Stegmeier joins Curie Bio and updates from Actinium, Lexeo and more
BioCentury | Oct 20, 2022
Deals

Oct. 19 Quick Takes: ‘Dark genome’ autoimmunity play Nucleome raises £37.5M series A

Plus venture rounds for Orionis, PIC, Inversago; PTC slips after pausing Huntington trial and more
BioCentury | Dec 7, 2021
Management Tracks

Biohaven names Coric chair, Buten CFO

Plus: Mutamba joins Arrakis as CBO and updates from Goldfinch, Kymera, AnHeart and more
BioCentury | Jul 13, 2021
Management Tracks

Berkley joins AbCellera as CBO; plus Genespire, Corcept, Shoreline and more

Antibody discovery company AbCellera Biologics Inc. (NASDAQ:ABCL) hired Neil Berkley as CBO.  Berkley joins from Halozyme Therapeutics Inc. (NASDAQ:HALO) where he was VP, head of business
BioCentury | Jul 8, 2021
Product Development

July 7 Quick Takes: Moderna launches flu trial of mRNA vaccine; plus Quidel recall, NIH, WHO, Boehringer-Lilly, Novartis and more

Moderna Inc. (NASDAQ:MRNA) dosed the first participants in a Phase I/II trial of quadrivalent seasonal mRNA influenza vaccine mRNA-1010 that will help determine whether the manufacturing and efficacy
BioCentury | Sep 8, 2020
Management Tracks

Black Diamond names Humphrey CMO; plus Edmondson to lead chemistry at Nimbus, Recce, Amarna and more

Rachel Humphrey has joined Black Diamond Therapeutics Inc. (NASDAQ:BDTX) as CMO. Karsten Witt, who has been SVP of clinical development and acting CMO since May 2019, will become SVP of non-clinical
BioCentury | Sep 27, 2019
Product Development

Reading into the first wave of neoantigen results

What early clinical data from neoantigen vaccines has taught the field about how to measure responses
BioCentury | Jun 4, 2019
Company News

Management tracks: Vericel, Theravance, Eisai

BioCentury | Dec 21, 2018
Company News

Amgen pulls out of Advaxis immunotherapy deal

Items per page:
1 - 10 of 155
Help Center
Username
Request Training
Submit Data Correction
Ask a Question